Global Medical Affairs Lead- Viral and Maternal, Vaccines

ROLE SUMMARY

Vaccines are one of the greatest public health advancements of all time, resulting in the control, elimination, or near-elimination of numerous infectious diseases that were once pervasive and often fatal. Pfizer has a rich history in vaccine research and development and have designed novel vaccines based on new delivery systems and technologies that have resulted in vaccines that prevent bacterial, vector and viral borne diseases. Over the years, we’ve played a pivotal role in eliminating or nearly eliminating deadly infectious diseases like smallpox and polio globally.

Today, Pfizer has an industry-leading portfolio of 19 approved vaccines and is committed to developing innovative solutions that prevent and treat disease, with special focus on maternal/neonatal and hospital-acquired infections (HAI).

In a highly visible role, the Global Viral and Maternal Lead will:

• Lead the Global Medical Affairs Strategy Heads and the Global Medical Strategy Directors to establish and develop medical strategy at an asset or franchise and pathogen level, in close collaboration with senior Pfizer Vaccine R&D stakeholders
• As a senior and respected subject matter expert in the clinical Vaccines community, the incumbent will drive Pfizer’s presence and reputation within the Vaccines clinical community and be a ‘go to’ person for key opinion leaders (KOLs) across their pathogens
• Build and develop a team of medical Vaccines experts that have strong knowledge in Vaccines, including the business environment, disease states, competitor data, asset data and synthesize into clear and effective medical strategy, enabling the effective pull through by the Medical Affairs local teams to unlock the full global potential of our existing and future commercially available medicines

The position has broad impact throughout the organization and requires a Vaccines medical professional with an understanding of pharmaceutical business operations (including product development), Vaccines R&D (including Research, early CMC Development, Clinical Development, Clinical Serology and Diagnostics and Operations), products, strategic thinking skills, leadership ability, and strong knowledge about and relationships within the external Vaccines stakeholder community.

The role will partner closely with Pfizer Vaccine R&D stakeholder groups (including Research, Early and Late Development, Regulatory Strategy, Clinical Development and Operations), and other Global Medical Affairs Leads within Pfizer Vaccine R&D, including those for Bacterial/Vector, International Developing Markets (ex US) and Emerging Markets. Outside of the Vaccines organization, partnership with Worldwide Medical, Comparative Medicine / Drug Safety Research and Development and Safety is also required to drive Viral and Maternal Medical Strategy across the organization.

ROLE RESPONSIBILITIES

This position reports directly to the Head of Medical, Vaccines, Pfizer Vaccine R&D and is a member of the Vaccines Medical Leadership Team (LT).

• This leader is accountable for the development of the global pathogen strategies and execution of individual programs, translating cross functional and geographic needs, and clinical / health system stakeholder insights into actionable research and medical deliverables to support the lightspeed development of innovative medicines that result in the control, elimination, or near-elimination of numerous infectious diseases that were once pervasive and often fatal.
• Responsible for Executive Medical Strategy leadership including:
  • Leadership of Medical Strategy on Pfizer Vaccine R&D governance committees
  • Partnership with Vaccines Medical Affairs leaders in all geographies and cross-functionally with Commercial, and Access and Value to establish an integrated community of experts and oversee the success of the assets within their indication areas
  • As a subject matter expert, this role is responsible for collaborating globally with KOLs and scientific experts to inform clinical development and medical strategies for their portfolio
  • Provide oversight and monitoring of the Scientific Engagement Program for their portfolio in collaboration with Medical Affairs leadership
  • Ensure the pathogen, indication and asset medical strategies deliver end-to-end medical excellence, starting with early development and continuing through the development lifecycle of the brand
  • As one of the Medical faces of the Pfizer Vaccine R&D organization for their portfolio, the incumbent will shape the evidence generation strategies in their portfolio by leveraging their deep expertise that enables the extraction of valuable medical insights from diverse stakeholders in the clinical community
  • Ensure continuity in evidence generation plans and